FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002273:Carcinogens; D003920:Diabetes Mellitus / Q000139:chemically induced; D004285:Dogs; D004338:Drug Combinations; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D000882:Haplorhini; D008321:Mammary Glands, Animal / Q000187:drug effects; D008598:Menstruation / Q000187:drug effects; D008656:Mestranol / Q000009:adverse effects; D009644:Norgestrel / Q000009:adverse effects; D011372:Progestins / Q000494:pharmacology*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D002273:Carcinogens; D004338:Drug Combinations; D004967:Estrogens; D011372:Progestins; D009644:Norgestrel; D008656:Mestranol